Skip to main content
Hamburger Menu Close

Advertisement

World

US FDA authorises COVID-19 vaccine boosters for the immunocompromised

US FDA authorises COVID-19 vaccine boosters for the immunocompromised

FILE PHOTO: Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration

Spurred by the Delta variant, coronavirus cases in the United States have spiked to their highest levels in more than six months, according to a Reuters tally.

Those with weak immune systems may not be sufficiently protected by their existing COVID-19 vaccinations, US health officials have said.

US regulators must fully authorise the COVID-19 vaccines or amend their emergency use approvals before officials can recommend additional shots. A panel of advisers to the US Centers for Disease Control and Prevention will meet on Friday to discuss eligibility of immunocompromised individuals for booster doses.

Wall Street analysts expect the authorisation of a booster dose for a broad population to bolster profits of COVID-19 vaccine makers, as hundreds of millions of fully inoculated people will come back for an extra dose.

BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Advertisement

RECOMMENDED

Advertisement